Let's look further into the dangers threatening Merck's crown jewel and decide whether the company's shares are worth buying anyway. To see how vital Keytruda is to Merck, it's important to look ...
Let's look further into the dangers threatening Merck's crown jewel and decide whether the company's shares are worth buying anyway. To see how vital Keytruda is to Merck, it's important to look at ...
RAHWAY, N.J., Oct. 10, 2024 /PRNewswire/ -- Dengue fever is a mosquito-borne viral infection that when mild, can cause flu-like symptoms. But in a more severe form, the virus can also lead to ...
On Monday, TD Cowen maintained its Buy rating on Merck & Co., Inc. (NYSE:MRK) shares, with a steadfast price target of $140.00. The firm highlighted Merck's favorable position compared to its ...
On Monday, TD Cowen maintained its Buy rating on Merck & Co., Inc. (NYSE:MRK) shares, with a steadfast price target of $140.00. The firm highlighted Merck's favorable position compared to its ...
Merck has traditionally eschewed large-scale M&A, but has been warming to the concept in recent years, with deals including its $11.5 billion takeover of Acceleron last year and its $2.75 billion ...
Chicago | Reuters — Merck and Co.’s animal health unit will buy privately-held Harrisvaccines to expand its portfolio of animal vaccines as the U.S. livestock industry seeks new defenses against ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results